Personal profile
Personal profile
Erik Nelson is a professor of Molecular and Integrative Physiology and is affiliated with the Division of Nutritional Sciences, Cancer Center at Illinois (Urbana), University of Illinois Cancer Center (Chicago), as well as the Anticancer Discovery from Pets to People research theme within the Carl R. Woese Institute for Genomic Biology.
Dr. Nelson has been named the 2025-2026 Dean’s Distinguished Professorial Scholar by the College of Liberal Arts and Sciences for his work on cholesterol metabolism and cancer.
Research Interests
Research Topics
Cell-Cell Interactions, Drug Discovery, Endocrinology, Metabolic Regulation, Regulation of Gene Expression, Signal Transduction
Disease Research Interests
Cancer, Drug Discovery
Education
2002 B.Sc. in Zoology, University of Calgary, Canada
2008 Ph.D. in Comparative Endocrinology, University of Calgary, Canada
2008-2014 Postdoctoral Associate, Duke University School of Medicine, Durham, NC
Professional Information
Endocrine and Metabolic Control of Breast and Ovarian Cancer Pathophysiology
Patients with metastatic breast and ovarian cancer continue to have a very poor prognosis. The magnitude of this problem provides a strong impetus for studies that may lead to new chemopreventative strategies and/or lifestyle changes that reduce morbidity from these cancers. Therefore, the goal of our research is to elucidate the effects of the endocrine system and metabolism on breast and ovarian cancer initiation and progression. We integrate our expertise in physiology, endocrinology, immunology and in vivo models to pursue translational breast and ovarian cancer research.
We have found that cholesterol metabolism plays critical roles in tumors, including in the immune cells that infiltrate tumors. We hope to leverage this knowledge to develop novel therapeutic approaches to treat breast and ovarian cancers.
The major focuses of the lab are:
- Using cholesterol biology to reprogram tumor associated immune cells.
- Defining the mechanisms by which cholesterol metabolites impact tumor progression and metastasis.
- Delineating the role of nuclear receptor signaling within the tumor microenvironment and its impact on tumor progression.
- Determining what regulates extracellular vesicles.
Honors & Awards
2021 Named the Era of Hope Scholar by the Department of Defense Breast Cancer Research Program
2020 Named the 2020-2021 I.C. Gunsalus Scholar at the University of Illinois
2016, 2017, 2018, 2020, 2021 List of Teachers Ranked Excellent By Their Students
2013 National Cancer Institute of the National Institutes of Health K99/R00 Pathway to Independence Award
2013 Robert J. Fitzgerald Academic Achievement Award. Department of Pharmacology and Cancer Biology, Duke University School of Medicine
2012 The Endocrine Society Award for Outstanding Paper in Endocrinology for 2011
2011 Robert J. Fitzgerald Scholar Award: Outstanding publication in the Department of Pharmacology and Cancer Biology, Duke University Medical Center
2009 Department of Defense Breast Cancer Research Program Postdoctoral Fellowship Award
2008 Government of Alberta Queen Elizabeth II Graduate Scholarship
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Cholesterol efflux protein, ABCA1, supports anticancer functions of myeloid immune cells
Bendre, S. V., Wang, Y., Hajyousif, B., Rajendra, K. C., Bhogale, S. G., Pradeep, D., Krawczynska, N., Schane, C. P., Weisser, E., Singh, A., Han, S., Kim, H., Kockaya, L., Gupta, A. D., Nelczyk, A. T., Gamage, H. E. V., Fei, Y., Rodríguez-Casiano, D., Guo, X. & Li, H. & 12 others, , Jan 2026, In: Science Advances. 12, 1, eadx5490.Research output: Contribution to journal › Article › peer-review
Open Access -
Neutrophils exposed to a cholesterol metabolite secrete extracellular vesicles that promote epithelial-mesenchymal transition and stemness in breast cancer cells
Krawczynska, N., Wang, Y., Lim, K., Das Gupta, A., Molino, R. J. E. J., Lenczowski, A., Abughazaleh, M., Bendre, S. V., Fei, Y., Kim, H., Kockaya, L. I., Schane, C. P., Pradeep, D., Rodriguez-Casiano, D., Hernandez, A. G., Drnevich, J., Chan, J., Dobrucki, L. W., Boppart, M. D. & Cologna, S. M. & 2 others, , Jan 1 2026, In: Cancer Letters. 636, 218105.Research output: Contribution to journal › Article › peer-review
Open Access -
Threonyl-tRNA synthetase activates STAT3 by a nontranslational mechanism[Figure presented]
Barai, P., Abdullah, R., Bendre, S. V., Weisser, E., van der Donk, M. J., Wong, K. L., Reyes-Ordoñez, A., Nelson, E. R. & Chen, J., Feb 2026, In: Journal of Biological Chemistry. 302, 2, 111032.Research output: Contribution to journal › Article › peer-review
Open Access -
A necrosis inducer promotes an immunogenic response and destroys ovarian cancers in mouse xenografts and patient ascites organoids
Duraki, D., Jabeen, M., Mao, C., Wang, L., Ghosh, S., Dai, X., Zhu, J., Boudreau, M. W., Nelson, E. R., Hergenrother, P. J., Cheng, G. & Shapiro, D. J., Aug 10 2025, In: Cancer Letters. 625, 217738.Research output: Contribution to journal › Article › peer-review
Open Access -
Cholesterol-targeting Wnt–β-catenin signaling inhibitors for colorectal cancer
Sharma, A., Zalejski, J., Bendre, S. V., Kavrokova, S., Hasdemir, H. S., Ozgulbas, D. G., Sun, J., Pathmasiri, K. C., Shi, R., Aloulou, A., Berkley, K., Delisle, C. F., Wang, Y., Weisser, E., Buweneka, P., Pierre-Jacques, D., Mukherjee, S., Abbasi, D. A., Lee, D. & Wang, B. & 5 others, , Apr 16 2025, (E-pub ahead of print) In: Nature chemical biology. 21, 9, p. 1376-1386 11 p.Research output: Contribution to journal › Article › peer-review
Open Access
Press/Media
-
Mice study suggests metabolic diseases may be driven by gut microbiome, loss of ovarian hormones
Nelson, E. R., Loman, B. R., Wallig, M. A. & Swanson, K. S.
2/22/24
1 Media contribution
Press/Media: Research
-
Team identifies key driver of cancer cell death pathway that activates immune cells
Nelson, E. R., Hergenrother, P. & Shapiro, D. J.
7/31/23
1 Media contribution
Press/Media: Research